Consorzio per Valutazioni Biologiche e Farmacologiche

Consorzio per Valutazioni Biologiche e Farmacologiche Informazioni di contatto, mappa e indicazioni stradali, modulo di contatto, orari di apertura, servizi, valutazioni, foto, video e annunci di Consorzio per Valutazioni Biologiche e Farmacologiche, Centro di ricerca medica, Pavia.

CVBF is a not-for-profit organisation, founded in 2000 with the mission to perform research and provide scientific, economic and regulatory consultancy for innovation in the health sector at European level. Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a not-for-profit organisation, founded in 2000 with the mission to perform research and provide scientific, economic and regulato

ry consultancy for innovation in the health sector at European level. The main fields of interest are life sciences and biotechnologies, drug development for small populations (pediatric and rare diseases), research management andmethodology, monitoring,statistics, regulatory, ethics and pharmacovigilance.

🔬 MAJOR BREAKTHROUGH IN RETT SYNDROME RESEARCH 🔬 We are proud to announce that CVBF will collaborate as a clinical resea...
03/03/2025

🔬 MAJOR BREAKTHROUGH IN RETT SYNDROME RESEARCH 🔬

We are proud to announce that CVBF will collaborate as a clinical research service provider for the world's first clinical trial on Mirtazapine for Rett Syndrome!

AIFA Agenzia Italiana del Farmaco - pagina ufficiale has approved the study, coordinated by the Università degli studi di Trieste under the guidance of Prof. Enrico Tongiorgi, which will involve 54 patients aged between 5 and 40 years across four major Italian clinical centers: Milan, Genoa, Siena, and Messina.

CVBF's mission is to facilitate and accelerate the development of medical products with particular attention to special populations, such as paediatric and rare disease ones. This project perfectly aligns with our core values and commitment to advancing treatments for vulnerable patient groups.

Why is this so important?
Rett Syndrome affects 1 in 10,000 girls and is the second leading cause of intellectual disability in female individuals. Currently, there is no definitive cure, but 15 years of research have shown promising results with Mirtazapine, which could improve motor skills, communication abilities, sleep disorders, respiratory and cardiac parameters.

This non-profit study is made possible thanks to the "Angelini for future" project by Angelini Pharma SpA and the generous support of Fondazione Canali Onlus, Ico Falck Onlus, and Amadei e Setti Onlus.

The CVBF team is excited to contribute to this potential therapeutic breakthrough that could significantly improve the quality of life for patients with Rett Syndrome and their families.

28/02/2025

Today, we celebrate the strength, courage, and resilience of those who face daily, often invisible challenges.

🎗️ 🎗️

This video was envisioned, filmed, and edited by KIDS Bari! A heartfelt thank you to them for their dedication, and our thoughts go out to everyone affected by rare diseases and their families.

"Together, we can raise awareness, drive research forward, and create a more inclusive future." 💜

TEDDY Network

28/02/2025

🎙️ Our Rare Disease Day 2025 Podcast is LIVE! 🎙️

We're thrilled to share that our special KIDS Albania podcast for is now available! This conversation features distinguished experts:

• Prof. Dr. MANIKA KREKA (Pediatrician, Hemoglobin Disorders specialist UHCT & Director of CVBF Albania)
• Prof. Dr. Anila Babameto-Laku (Medical Genetics Professor & Head of Genetic Laboratory Service, UHCT)

Our youth participants engaged the experts with thought-provoking questions:
- Enio explored what defines rare diseases and their prevalence in Albania
- Dion asked about healthcare obstacles faced by rare disease patients and societal inclusion
- Niki highlighted the critical importance of screening rare diseases at birth
- Fiona discussed gene therapies and the role of clinical trials in developing new treatments

This conversation was made possible through collaboration with TEDDY and CVBF, and moderated by Ornela Cullufe, Team Leader of KIDS Albania. We're proud to see our youth taking the lead in raising awareness about rare diseases!

🔗 Watch the full podcast now!

Let's continue supporting those affected by rare diseases by sharing knowledge and building understanding.

🎉 CVBF obtains the Family Audit Executive Certification!We are proud to announce that CVBF has achieved the Family Audit...
14/01/2025

🎉 CVBF obtains the Family Audit Executive Certification!

We are proud to announce that CVBF has achieved the Family Audit Executive Certification, recognizing our commitment to promoting work-life balance policies and fostering organizational well-being.

In recent years, we have introduced tangible initiatives to enhance the quality of life for our employees, including:
✅ Flexible working hours for entry and exit
✅ Baby bonuses for new births
✅ Performance-based reward systems
✅ Financial reimbursements for unexpected family care needs

These measures have not only improved the well-being of our team but have also strengthened employee loyalty, fostering longer tenure and sustainable growth across our workforce.

The certification does not represent a final destination but rather serves as motivation to continue our commitment to creating a workplace that is increasingly inclusive and responsive to everyone's needs.

hashtag hashtag hashtag hashtag hashtag hashtag

27/11/2024

🚨 Exciting Announcement from ERDERA! 🚨

We are thrilled to pre-announce our 2025 Joint Transnational Call for Proposals focused on pre-clinical therapy studies for rare diseases using small molecules and biologicals.

🧬🌍 This call offers a unique opportunity for researchers worldwide to collaborate on groundbreaking research that can potentially improve the lives of millions affected by rare diseases.

📅 Important Dates:
Call Opens: December 10, 2024
Pre-Proposal Deadline: February 13, 2025

💡 Key topics include novel therapies, biomarkers, and proof-of-concept studies.

We're encouraging partnerships with Early Career Researchers and Patient Advocacy Organizations to create an inclusive, interdisciplinary research environment.

Read more about the call details here: https://loom.ly/-YEsh3Y

Stay tuned for more details and mark your calendars for our information webinar on December 17th!

Please note that this is a draft announcement and the list of funders is not final.

https://tinyurl.com/jmretnry

Join ERDERA Launch Event Online Next 28 October!  Event Details:  🗓 Date: 28 October 2024 🕒 Time: 14:00 - 16:15 CET 📍 Lo...
21/10/2024

Join ERDERA Launch Event Online Next 28 October!

Event Details:

🗓 Date: 28 October 2024
🕒 Time: 14:00 - 16:15 CET
📍 Location: Online

More information👉https://loom.ly/roZC5QM
Register ✏️https://loom.ly/yVfXdrY

Join ERDERA Launch Event Online Next 28 October!

Be part of the official launch of the European Partnership on Rare Diseases (ERDERA)—a groundbreaking initiative aiming to transform the lives of 30 million rare disease patients across Europe.

Event Details:

🗓 Date: 28 October 2024
🕒 Time: 14:00 - 16:15 CET
📍 Location: Online

Key Highlights:

➡️ Hear from top EU policymakers, rare disease experts, and thought leaders
➡️ Discover more about ERDERA, the new EU partnership bringing together over 170 organizations to promote rare disease research and innovation.
➡️Follow live presentations from Daria Julkowska, ERDERA Scientific Coordinator, and other influential speakers.

Don’t miss out on this opportunity to learn what is next in rare disease research!

More information👉https://loom.ly/roZC5QM
Register ✏️https://loom.ly/yVfXdrY

27/09/2024

🎉 Exciting news from Kosovo! 🇽🇰 Last week, we spent two incredible days in Pristina, diving into the future of clinical trials in Europe's newest country. Led by Donato Bonifazi, member of the Board of Directors of TEDDY and CEO of CVBF, we had the privilege of visiting the Children's Hospital at QKUK and engaging in fruitful discussions with local stakeholders.

🚀 Kosovo stands at the verge of an exciting journey in clinical research. While trials are yet to begin, the energy and enthusiasm we encountered were truly inspiring. Young Persons Advisory Group KIDS Kosova is eager to support and collaborate with local partners, focusing especially on rare diseases and paediatric populations.

🤝 We're honored to be among the pioneers in this field, working to create more efficient and impactful clinical trials in Kosovo. The passion and drive we witnessed during our visit left us feeling optimistic about the future of medical research in this vibrant country.

🎈Here's to new beginnings and the bright future of clinical trials in Kosovo! We can't wait to see what we'll achieve together.

17/09/2024

🔥 NEW DATES ALERT! 🔥

🔬 Are you a teenager between 12 and 18 years old living with arthritis or multiple sclerosis?

Do you want to make a difference in scientific research and help shape the future of healthcare for young people like you?
Join the Pediatric Patient Expert Group (PEG) organized by TEDDY Network and become a key player in the project! 🚀

👉 Updated course dates:
📅 2-3 November 2024
📍 Bari, Italy
⚠️ New extended deadline to apply: 27 September 2024.

🔗 Don't miss out! Find out more and sign up here: https://invents-he.eu/recruitment/

Indirizzo

Pavia

Orario di apertura

Lunedì 09:00 - 18:30
Martedì 09:00 - 18:30
Mercoledì 09:00 - 18:30
Giovedì 09:00 - 18:30
Venerdì 09:00 - 18:30

Telefono

+39038225075

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Consorzio per Valutazioni Biologiche e Farmacologiche pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Consorzio per Valutazioni Biologiche e Farmacologiche:

Condividi